Cortexyme logo
Cortexyme CRTX

Quarterly report 2025-Q3
added 11-12-2025

report update icon

Cortexyme Long Term Debt Current 2011-2026 | CRTX

Annual Long Term Debt Current Cortexyme

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
64 K 377 K 741 K 238 K - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
741 K 64 K 355 K

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.56 M $ 1.35 -2.91 % $ 359 M britainBritain
Coherus BioSciences Coherus BioSciences
CHRS
1.83 M $ 1.61 -3.59 % $ 189 M usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
437 K $ 24.88 -0.4 % $ 3.04 B usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
1.63 M $ 10.02 -1.16 % $ 133 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
730 K $ 1.57 -0.63 % $ 105 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 3.65 1.3 % $ 8.78 B australiaAustralia
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
DBV Technologies S.A. DBV Technologies S.A.
DBVT
1.12 M $ 20.25 -0.54 % $ 2.83 B franceFrance
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
137 K $ 2.55 -4.14 % $ 16 M usaUSA
Dyadic International Dyadic International
DYAI
34.6 K $ 0.87 - $ 31.5 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Entera Bio Ltd. Entera Bio Ltd.
ENTX
189 K $ 1.17 -2.1 % $ 64 M israelIsrael
Equillium Equillium
EQ
363 K $ 2.0 -0.5 % $ 115 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Evogene Ltd. Evogene Ltd.
EVGN
589 K $ 0.8 2.49 % $ 27.9 M israelIsrael
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Fate Therapeutics Fate Therapeutics
FATE
4.56 M $ 1.15 -3.78 % $ 137 M usaUSA
Forte Biosciences Forte Biosciences
FBRX
416 K $ 26.15 -1.1 % $ 339 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
Fennec Pharmaceuticals Fennec Pharmaceuticals
FENC
2 K $ 6.2 -3.43 % $ 177 M usaUSA
Foghorn Therapeutics Foghorn Therapeutics
FHTX
923 K $ 4.75 -2.59 % $ 299 M usaUSA
Amicus Therapeutics Amicus Therapeutics
FOLD
8.74 M $ 14.46 0.03 % $ 4.46 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
BioNTech SE BioNTech SE
BNTX
45 M $ 88.37 -3.19 % $ 27.2 B germanyGermany
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Fulcrum Therapeutics Fulcrum Therapeutics
FULC
2.4 M $ 7.45 -4.85 % $ 472 K usaUSA
Galectin Therapeutics Galectin Therapeutics
GALT
22 K $ 2.38 -7.03 % $ 152 M usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
45.5 M $ 315.4 -4.52 % $ 41.3 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
756 K - - $ 2.17 B usaUSA
Gilead Sciences Gilead Sciences
GILD
102 M $ 138.37 -1.26 % $ 172 B usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
48 K - 10.36 % $ 9.8 M usaUSA
Genmab A/S Genmab A/S
GMAB
26 M $ 27.13 -2.25 % $ 17 B danmarkDanmark
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA